Analysis of caesarean sections using Robson 10-group classification system in a university hospital in eastern Ethiopia: a cross-sectional study

ObjectiveTo analyse caesarean section (CS) using Robson 10-group classification system in an Ethiopian university hospital.DesignCross-sectional study.SettingA university hospital in eastern, Ethiopia.Participants980 women who underwent CS from January 2016 to April 2017.Main outcomeRobson groups (1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ open 2018-04, Vol.8 (4), p.e020520-e020520
Hauptverfasser: Tura, Abera Kenay, Pijpers, Olga, de Man, Myrna, Cleveringa, Myrthe, Koopmans, Ingeborg, Gure, Tadesse, Stekelenburg, Jelle
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ObjectiveTo analyse caesarean section (CS) using Robson 10-group classification system in an Ethiopian university hospital.DesignCross-sectional study.SettingA university hospital in eastern, Ethiopia.Participants980 women who underwent CS from January 2016 to April 2017.Main outcomeRobson groups (1–10—based on gestational age, fetal presentation, number of fetus, onset of labour and history of CS) and indications for CS.ResultsRobson group 3 (multiparous women with single cephalic full-term pregnancy in spontaneous labour with no history of CS), group 5 (multiparous women with single cephalic full-term pregnancy with history of CS) and group 1 (single cephalic nulliparous women full-term pregnancy in spontaneous labour) were the major contributors to the overall CS at 21.4%, 21.1% and 19.3%, respectively. The three major indications for CS were fetal compromise (mainly fetal distress), obstructed labour (mainly cephalopelvic disproportion) and previous CS.ConclusionRobson groups 3, 5 and 1 were the major contributors to the overall CS rate. Fetal compromise, obstructed labour and previous CS were the underlying indications for performing CS. Further study is required to assess the appropriateness of the indications and to reduce CS among the low-risk groups (groups 1 and 3).
ISSN:2044-6055
2044-6055
DOI:10.1136/bmjopen-2017-020520